Full Committee Hearing
FDA User Fee Agreements: Strengthening FDA and the Medical Products Industry for the Benefit of Patients
Date: Thursday, March 29, 2012
Time: 10:00 AM
Location: 216 Hart Senate Office Building
This content requires Flash Player version 9 (installed version: No Flash Flayer installed, or version is pre 6.0.0
Install Flash Player
Open in New Window Open in New Window
Witnesses
Panel I
-
Janet
Woodcock, M.D.
Director
Center for Drug Evaluation and Research, Food and Drug Administration
Silver Spring, MD
-
Jeffrey
Shuren, M.D., J.D.
Director
Center for Devices and Radiological Health, Food and Drug Administration
Silver Spring, MD
Panel II
-
David
Wheadon, M.D.
Senior Vice President of Scientific and Regulatory Affairs
Pharmaceutical Research and Manufacturers of America
Washington, DC
-
Sara
Radcliffe
Executive Vice President
Health, Biotechnology Industry Organization
Washington, DC
-
David R.
Gaugh, R.Ph.
Vice President for Regulatory Affairs
Generic Pharmaceutical Association
Washington, DC
-
David
Nexon, Ph.D.
Senior Executive Vice President
Advanced Medical Technology Association
Washington, DC
-
Allan
Coukell, BScPharm
Director of Medical Programs, The Pew Charitable Trusts
Washington, DC